SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6
http://www.w3.org/2000/01/rdf-schema#comment
"KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_6A3E01A7F0DD7863BDC641EC6AA6C306A3F8AAD68364957BA729C49DDE64E07735A39D09EAA7756A75A6D38589FBCBDA
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6
http://purl.uniprot.org/uniprot/B5TY33
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6
http://purl.uniprot.org/uniprot/#_B5TY33-mappedCitation-28988130
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/69DE122DCAE1CC496A04110D16206D76FF6C89E47EDF06181DF70FE8AE0F313D279A4784F34037DCFF4C0605146E92E6